IFA
Invus Financial Advisors Portfolio holdings
AUM
$89.2M
This Quarter Return
+29.75%
1 Year Return
-10.79%
3 Year Return
-29.46%
5 Year Return
–
10 Year Return
–
AUM
$277M
AUM Growth
+$277M
(+36%)
Cap. Flow
+$39.1M
Cap. Flow
% of AUM
14.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Oric Pharmaceuticals
ORIC
|
$34M |
| 2 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
$5.16M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 74.62% |
| 2 | Technology | 25.05% |
| 3 | Consumer Staples | 0.24% |
| 4 | Consumer Discretionary | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $80M | 28.9% |
2,768,586
+178,571
| +7% | +$5.16M |
|
2
Yext
YEXT
$1.11B
| $68.9M | 24.89% |
4,146,784
| – | – |
|
3
Arcus Biosciences
RCUS
$1.13B
| $45.6M | 16.47% |
1,842,077
| – | – |
|
|
4
Oric Pharmaceuticals
ORIC
$994M
| $34M | 12.28% |
+1,007,576
| New | +$34M |
|
5
NovoCure
NVCR
$1.38B
| $27.9M | 10.09% |
470,884
| – | – |
|
|
UBX
6
DELISTED
Unity Biotechnology
UBX
| $19M | 6.87% |
2,189,998
| – | – |
|
7
Chegg
CHGG
$159M
| $664K | 0.24% |
9,868
| – | – |
|
8
Sunrun
RUN
$3.68B
| $427K | 0.15% |
21,657
| – | – |
|
9
Alibaba
BABA
$322B
| $261K | 0.09% |
1,211
| – | – |
|